The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence and differentiation of hereditary breast and ovarian cancer in Japan.
Seigo Nakamura
No relevant relationships to disclose
Takuji Iwase
No relevant relationships to disclose
Seiichiro Nishimura
Honoraria - Falco Biosystems
Hideko Yamauchi
Honoraria - Falco Biosystems
Tadashi Nomizu
No relevant relationships to disclose
Shozo Ohsumi
No relevant relationships to disclose
Masato Takahashi
No relevant relationships to disclose
Shinichi Baba
No relevant relationships to disclose
Tadao Shimizu
No relevant relationships to disclose